In 2011, nearly 100 million wounds were treated in U.S. hospitals; these included amputations; arterial, diabetic, pressure, and venous ulcers; burns, surgical wounds; and traumatic wounds. In the same year, treatment of these wounds generated more than $3.8 billion in wound closure product sales (including traditional products such as sutures, stapling systems, and wound closure strips, as well as emerging products such as surgical sealants and glues, energy-based closure devices, automated suturing products, and negative pressure wound therapy systems). Over the forecast period covered by this report, sales of traditional and emerging wound closure products are expected to increase at a compound annual rate of 4.0%, reaching more than $4.6 billion in the year 2016.
This new report by Medtech Insight presents a detailed overview of the U.S. current and emerging wound closure products market. Major topics covered by this report include a an overview of the physiology of wound closure; a discussion of traditional wound closure products such as sutures, stapling products, and wound closure strips; a discussion of emerging wound closure products such as surgical sealants and glues, energy-based closure devices, automated suturing devices, and negative pressure wound therapy products; and analyses of the sales and leading competitors in each of these markets.
Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.